COVID-19 in Germany and China: mitigation versus elimination strategy

Lu G, Razum O, Jahn A, Zhang Y, Sutton B, Sridhar D, Ariyoshi K, von Seidlein L, Muller O (2021)
Global health action 14(1): 1875601.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Lu, Guangyu; Razum, OliverUniBi; Jahn, Albrecht; Zhang, Yuying; Sutton, Brett; Sridhar, Devi; Ariyoshi, Koya; von Seidlein, Lorenz; Muller, Olaf
Abstract / Bemerkung
Background: The COVID-19 pandemic shows variable dynamics in WHO Regions, with lowest disease burden in the Western-Pacific Region. While China has been able to rapidly eliminate transmission of SARS-CoV-2, Germany - as well as most of Europe and the Americas - is struggling with high numbers of cases and deaths. Objective: We analyse COVID-19 epidemiology and control strategies in China and in Germany, two countries which have chosen profoundly different approaches to deal with the epidemic. Methods: In this narrative review, we searched the literature from 1 December 2019, to 4 December 2020. Results: China and several neighbours (e.g. Australia, Japan, South Korea, New Zealand, Thailand) have achieved COVID-19 elimination or sustained low case numbers. This can be attributed to: (1) experience with previous coronavirus outbreaks; (2) classification of SARS-CoV-2 in the highest risk category and consequent early employment of aggressive control measures; (3) mandatory isolation of cases and contacts in institutions; (4) broad employment of modern contact tracking technology; (5) travel restrictions to prevent SARS-CoV-2 re-importation; (6) cohesive communities with varying levels of social control. Conclusions: Early implementation of intense and sustained control measures is key to achieving a near normal social and economic life.
Erscheinungsjahr
2021
Zeitschriftentitel
Global health action
Band
14
Ausgabe
1
Art.-Nr.
1875601
eISSN
1654-9880
Page URI
https://pub.uni-bielefeld.de/record/2950418

Zitieren

Lu G, Razum O, Jahn A, et al. COVID-19 in Germany and China: mitigation versus elimination strategy. Global health action. 2021;14(1): 1875601.
Lu, G., Razum, O., Jahn, A., Zhang, Y., Sutton, B., Sridhar, D., Ariyoshi, K., et al. (2021). COVID-19 in Germany and China: mitigation versus elimination strategy. Global health action, 14(1), 1875601. doi:10.1080/16549716.2021.1875601
Lu, G., Razum, O., Jahn, A., Zhang, Y., Sutton, B., Sridhar, D., Ariyoshi, K., von Seidlein, L., and Muller, O. (2021). COVID-19 in Germany and China: mitigation versus elimination strategy. Global health action 14:1875601.
Lu, G., et al., 2021. COVID-19 in Germany and China: mitigation versus elimination strategy. Global health action, 14(1): 1875601.
G. Lu, et al., “COVID-19 in Germany and China: mitigation versus elimination strategy”, Global health action, vol. 14, 2021, : 1875601.
Lu, G., Razum, O., Jahn, A., Zhang, Y., Sutton, B., Sridhar, D., Ariyoshi, K., von Seidlein, L., Muller, O.: COVID-19 in Germany and China: mitigation versus elimination strategy. Global health action. 14, : 1875601 (2021).
Lu, Guangyu, Razum, Oliver, Jahn, Albrecht, Zhang, Yuying, Sutton, Brett, Sridhar, Devi, Ariyoshi, Koya, von Seidlein, Lorenz, and Muller, Olaf. “COVID-19 in Germany and China: mitigation versus elimination strategy”. Global health action 14.1 (2021): 1875601.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 33472568
PubMed | Europe PMC

Suchen in

Google Scholar